Estrogen receptor antagonist
PH12021551437B1Active Publication Date: 2026-08-14CHIA TAI TIANQING PHARMA GRP CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021551437
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-06-17
- Publication Date
- 2026-08-14
- Estimated Expiration
- 2041-06-17
Abstract
Provided is an indole compound. In particular, disclosed are a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof and a use of the same as an estrogen receptor antagonist in preparing a drug for treating estrogen receptor-positive breast cancer.
Need to check novelty before this filing date? Find Prior Art